VEEV was developed as a biological weapon by the United States and the former Soviet Union during the Cold War. It is classified as a biosafety level 3 by the Centers for Disease Control and as a category B priority pathogen by the National Institute of Allergies and Infectious Diseases.[2] Laboratory accidents have been reported, with infections occurring from small-volume aerosolized samples.